Building Better Beta Cells

Edouard Stanley; Andrew George Elefanty

Building Better Beta Cells

Edouard Stanley, Andrew George Elefanty

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.

Original language	English
Pages (from-to)	300 - 301
Number of pages	2
Journal	Cell Stem Cell
Volume	2
Issue number	4
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{fbdcabcd32934805b7fc46abba176ef8,

title = "Building Better Beta Cells",

abstract = "Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.",

author = "Edouard Stanley and Elefanty, {Andrew George}",

year = "2008",

language = "English",

volume = "2",

pages = "300 -- 301",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Building Better Beta Cells

AU - Stanley, Edouard

AU - Elefanty, Andrew George

PY - 2008

Y1 - 2008

N2 - Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.

AB - Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18397747

M3 - Article

SN - 1934-5909

VL - 2

SP - 300

EP - 301

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 4

ER -

Building Better Beta Cells

Abstract

UN SDGs

Other files and links

Cite this